Back to mobile site

Matinas BioPharma (MTNB) Announces Patrick G. LePore to Board

September 6, 2018 8:17 AM EDT Send to a Friend
Matinas BioPharma Holdings, Inc. (NYSE: MTNB), a clinical-stage biopharmaceutical company focused on enabling targeted intracellular delivery of life-changing medicines using ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login